Literature DB >> 1530984

Multiple binding sites on the CH2 domain of IgG for mouse Fc gamma R11.

J Lund1, J D Pound, P T Jones, A R Duncan, T Bentley, M Goodall, B A Levine, R Jefferis, G Winter.   

Abstract

Important mammalian defensive functions such as phagocytosis are triggered in leukocytes by the interaction of the Fc region of IgG with cell surface receptors (Fc gamma R). The CH2 domain of IgG has been implicated previously as the site of interaction with human and mouse Fc gamma R. This domain was mapped for interaction with mouse Fc gamma R11 expressed by the macrophage-like cell line P388D1, using two panels of a total of 32 site-directed mutants of mouse IgG2b and chimeric human IgG3 monoclonal antibodies. Two potential binding sites have been identified: one in or within the vicinity of the lower hinge site on IgG for human Fc gamma R1, and one within the binding site on IgG for Clq. The three mutant IgGs (Gly 237----Ala, Asn 297----Ala, and Glu 318----Ala) which do not interact in complexed form also fail to bind as monomers. A 1H NMR study of the three non-binding monomeric mutants suggests that the mutations are largely site-specific, indicating that IgG interacts with mouse Fc gamma R11 at two regions within the CH2 domain. This interaction dictates phagocytosis mediated by Fc gamma R11 of the P388D1 cell line.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1530984     DOI: 10.1016/0161-5890(92)90156-r

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  12 in total

1.  Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1.

Authors:  M Hezareh; A J Hessell; R C Jensen; J G van de Winkel; P W Parren
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Activation of effector functions by immune complexes of mouse IgG2a with isotype-specific autoantibodies.

Authors:  E Rajnavölgyi; G Fazekas; J Lund; M Daeron; J L Teillaud; R Jefferis; W H Fridman; J Gergely
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

3.  High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains.

Authors:  H G Cheon; W J LaRochelle; D P Bottaro; W H Burgess; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

4.  Antigen-Induced Allosteric Changes in a Human IgG1 Fc Increase Low-Affinity Fcγ Receptor Binding.

Authors:  Chiara Orlandi; Daniel Deredge; Krishanu Ray; Neelakshi Gohain; William Tolbert; Anthony L DeVico; Patrick Wintrode; Marzena Pazgier; George K Lewis
Journal:  Structure       Date:  2020-03-24       Impact factor: 5.006

5.  MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments.

Authors:  Heleen Scheerens; Zheng Su; Bryan Irving; Michael J Townsend; Yanan Zheng; Eric Stefanich; Vishala Chindalore; Clifton O Bingham; John C Davis
Journal:  Arthritis Res Ther       Date:  2011-10-26       Impact factor: 5.156

6.  Glyco-Engineered Anti-Human Programmed Death-Ligand 1 Antibody Mediates Stronger CD8 T Cell Activation Than Its Normal Glycosylated and Non-Glycosylated Counterparts.

Authors:  Christoph Goletz; Timo Lischke; Ulf Harnack; Phillip Schiele; Antje Danielczyk; Johanna Rühmann; Steffen Goletz
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

Review 7.  Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life.

Authors:  Kevin O Saunders
Journal:  Front Immunol       Date:  2019-06-07       Impact factor: 7.561

Review 8.  Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function.

Authors:  Andrew R Crowley; Margaret E Ackerman
Journal:  Front Immunol       Date:  2019-04-08       Impact factor: 7.561

9.  Identification of cyclic peptides able to mimic the functional epitope of IgG1-Fc for human Fc gammaRI.

Authors:  Stephane Bonetto; Loredana Spadola; Andrew G Buchanan; Lutz Jermutus; John Lund
Journal:  FASEB J       Date:  2008-10-28       Impact factor: 5.191

10.  Insertion of N-Terminal Hinge Glycosylation Enhances Interactions of the Fc Region of Human IgG1 Monomers with Glycan-Dependent Receptors and Blocks Hemagglutination by the Influenza Virus.

Authors:  Patricia A Blundell; Dongli Lu; Mark Wilkinson; Anne Dell; Stuart Haslam; Richard J Pleass
Journal:  J Immunol       Date:  2019-01-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.